Prevention of atrial oxidative stress and electrical remodelling in patients undergoing cardiac surgery: randomised placebo-controlled trial of perioperative high-dose atorvastatin

Trial Profile

Prevention of atrial oxidative stress and electrical remodelling in patients undergoing cardiac surgery: randomised placebo-controlled trial of perioperative high-dose atorvastatin

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Aug 2014

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Atrial fibrillation
  • Focus Biomarker; Therapeutic Use
  • Acronyms STARR
  • Most Recent Events

    • 14 May 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 30 Jan 2013 Planned End Date changed from 6 Jul 2013 to 1 Feb 2014 as reported by ClinicalTrials.gov.
    • 30 Jan 2013 New source identified and integrated (ClinicalTrials.gov record: NCT01780740).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top